CPSF1
Basic information
Region (hg38): 8:144393229-144409335
Links
Phenotypes
GenCC
Source:
- myopia 27 (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Myopia 27, autosomal dominant | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 30689892 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CPSF1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 90 | 90 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 2 | 1 | 3 | |||
non coding | 0 | |||||
Total | 2 | 2 | 91 | 6 | 1 |
Highest pathogenic variant AF is 0.0000328
Variants in CPSF1
This is a list of pathogenic ClinVar variants found in the CPSF1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-144393343-G-A | not specified | Uncertain significance (Dec 17, 2021) | ||
8-144393454-T-C | not specified | Uncertain significance (Aug 11, 2023) | ||
8-144393497-C-A | not specified | Uncertain significance (Oct 25, 2024) | ||
8-144393529-G-T | not specified | Uncertain significance (Dec 18, 2023) | ||
8-144393547-T-G | not specified | Uncertain significance (Jan 16, 2024) | ||
8-144393570-C-T | not specified | Uncertain significance (Sep 03, 2024) | ||
8-144393592-T-C | Myopia 27 | Pathogenic (Mar 27, 2020) | ||
8-144393595-GGC-G | CPSF1-related disorder | Likely benign (Apr 10, 2023) | ||
8-144393689-C-T | not specified | Uncertain significance (Mar 22, 2022) | ||
8-144393705-C-T | not specified | Uncertain significance (Jan 24, 2024) | ||
8-144393913-C-T | not specified | Uncertain significance (Sep 08, 2024) | ||
8-144393943-C-T | not specified | Uncertain significance (Nov 04, 2023) | ||
8-144393976-C-T | not specified | Uncertain significance (Jul 14, 2024) | ||
8-144393988-C-A | not specified | Uncertain significance (Jun 01, 2023) | ||
8-144393988-C-T | not specified | Uncertain significance (Jan 31, 2023) | ||
8-144394005-C-T | not specified | Uncertain significance (Jan 22, 2024) | ||
8-144394024-C-T | not specified | Uncertain significance (May 20, 2024) | ||
8-144394149-C-A | Myopia 27 | Pathogenic (Mar 27, 2020) | ||
8-144394411-C-T | not specified | Uncertain significance (Jun 29, 2023) | ||
8-144394449-G-A | not specified | Uncertain significance (Apr 25, 2022) | ||
8-144394460-G-C | not specified | Uncertain significance (Apr 11, 2023) | ||
8-144394471-C-T | not specified | Uncertain significance (Oct 13, 2023) | ||
8-144394692-G-A | CPSF1-related disorder | Likely benign (May 31, 2023) | ||
8-144394947-G-T | not specified | Uncertain significance (May 17, 2023) | ||
8-144394956-C-T | not specified | Uncertain significance (Nov 10, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CPSF1 | protein_coding | protein_coding | ENST00000349769 | 37 | 16310 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.10e-10 | 1.00 | 125565 | 0 | 172 | 125737 | 0.000684 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.80 | 719 | 964 | 0.746 | 0.0000668 | 9325 |
Missense in Polyphen | 173 | 333.37 | 0.51895 | 3253 | ||
Synonymous | -3.05 | 508 | 428 | 1.19 | 0.0000332 | 2919 |
Loss of Function | 4.84 | 30 | 75.3 | 0.398 | 0.00000365 | 822 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00466 | 0.00341 |
Ashkenazi Jewish | 0.00246 | 0.00159 |
East Asian | 0.000496 | 0.000489 |
Finnish | 0.0000476 | 0.0000462 |
European (Non-Finnish) | 0.000808 | 0.000598 |
Middle Eastern | 0.000496 | 0.000489 |
South Asian | 0.000430 | 0.000425 |
Other | 0.000843 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the cleavage and polyadenylation specificity factor (CPSF) complex that plays a key role in pre- mRNA 3'-end formation, recognizing the AAUAAA signal sequence and interacting with poly(A) polymerase and other factors to bring about cleavage and poly(A) addition. This subunit is involved in the RNA recognition step of the polyadenylation reaction. {ECO:0000269|PubMed:14749727}.;
- Pathway
- mRNA surveillance pathway - Homo sapiens (human);mRNA Processing;tRNA processing;Gene expression (Transcription);polyadenylation of mrna;RNA Polymerase II Transcription;Metabolism of RNA;Processing of Intronless Pre-mRNAs;Processing of Capped Intronless Pre-mRNA;Cleavage of Growing Transcript in the Termination Region ;RNA Polymerase II Transcription Termination;mRNA Splicing - Major Pathway;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;tRNA processing in the nucleus;mRNA Splicing;mRNA 3,-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA
(Consensus)
Recessive Scores
- pRec
- 0.131
Intolerance Scores
- loftool
- 0.668
- rvis_EVS
- -3.4
- rvis_percentile_EVS
- 0.37
Haploinsufficiency Scores
- pHI
- 0.244
- hipred
- Y
- hipred_score
- 0.563
- ghis
- 0.642
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.911
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cpsf1
- Phenotype
Zebrafish Information Network
- Gene name
- cpsf1
- Affected structure
- hematopoietic stem cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- mRNA splicing, via spliceosome;termination of RNA polymerase II transcription;mRNA polyadenylation;mRNA export from nucleus;mRNA 3'-end processing;pre-mRNA cleavage required for polyadenylation
- Cellular component
- nucleus;nucleoplasm;mRNA cleavage and polyadenylation specificity factor complex
- Molecular function
- protein binding;enzyme binding;mRNA 3'-UTR AU-rich region binding